1. Copyright © 2003 American Medical Association. All rights reserved.
From: Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceThe STOP-NIDDM Trial
JAMA. 2003;290(4): doi: /jama
Figure Legend:
IGT, impaired glucose tolerance; STOP-NIDDM, STOP-Noninsulin-DependentDiabetes Mellitus.
Date of download: 10/21/2017
Copyright © 2003 American Medical Association. All rights reserved.

2. Copyright © 2003 American Medical Association. All rights reserved.
From: Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceThe STOP-NIDDM Trial
JAMA. 2003;290(4): doi: /jama
Date of download: 10/21/2017
Copyright © 2003 American Medical Association. All rights reserved.

3. Copyright © 2003 American Medical Association. All rights reserved.
From: Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceThe STOP-NIDDM Trial
JAMA. 2003;290(4): doi: /jama
Figure Legend:
CI, confidence interval. Asterisk indicates hazard ratio (95% CI)could not be calculated because of zero event for acarbose group.
Date of download: 10/21/2017
Copyright © 2003 American Medical Association. All rights reserved.

4. Copyright © 2003 American Medical Association. All rights reserved.
From: Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceThe STOP-NIDDM Trial
JAMA. 2003;290(4): doi: /jama
Date of download: 10/21/2017
Copyright © 2003 American Medical Association. All rights reserved.

5. Copyright © 2003 American Medical Association. All rights reserved.
From: Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceThe STOP-NIDDM Trial
JAMA. 2003;290(4): doi: /jama
Date of download: 10/21/2017
Copyright © 2003 American Medical Association. All rights reserved.